The dynamic duo driving global growth

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with James Lovett, CEO and Mike Cohen, Executive Chairman at Myonex.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with James and Mike, covering:

• How a family-owned pharmacy became a major global clinical trial supplies business… two generations later
• Mike’s decision to bring in a CEO and the challenge of letting go… before seeing the data points of success
• James’ decision to take on the baton and fuel organic and inorganic growth through client-centricity
• The decision not to take investment and instead ‘run our own play’ using some of PE’s tried and tested playbook
• Why this industry will always grow due to unmet medical needs and breakthroughs in science

Michael’s passion and commitment have been a driving force in making Myonex, a global leader in clinical trial supply. Under his leadership, Myonex has expanded its service offerings and strengthened manufacturer and sourcing relationships, opened new locations and expanded the employee base. Today Michael focuses on strategic growth opportunities. Before Myonex, he served in executive positions in the publishing, advertising, financial and utility industries. He holds a BS in Statistics from the University of Pittsburgh and an MBA from the university’s Katz Graduate School of Business.

James is driven to help clients deliver medical advances, to develop team members, and to lead Myonex to continued success. Before joining Myonex in 2017 as Chief Operating Officer, James was SVP of Covance, where he led three business units, was General Counsel and served on the Executive Committee. He was named Myonex CEO in 2019. He also serves on the Board of Directors of Food Chain ID and the Board of Trustees of the Wistar Institute. James has played leadership roles in the Association of Clinical Research Organizations and the National Association for Biomedical Research. He is a graduate of Northwestern University and Harvard Law School.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is also sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.